You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Next-Generation Ear Seals for Circumaural Headsets and Hearing Protectors

    SBC: Hearing Components, Inc.            Topic: DHA172007

    The objective of this proposal is to demonstrate the feasibility of producing molded polyurethane viscoelastic foam ear seals with an integral skin, that we call Contoured Foam Pads (CFPs). These CFPs will have a surface profile that has targeted conformability around obstacles that results in an improved acoustic seal around eyeglasses from the military Approved Protective Eyewear List (APEL) and ...

    SBIR Phase I 2018 Department of DefenseDefense Health Agency
  2. Complex Crystalloid Resuscitative Fluid

    SBC: GanD, Inc.            Topic: DHA172009

    The published data has demonstrated that the currently available resuscitation fluids have detrimental effects on trauma outcomes.By addressing these deficiencies it is expected that the outcomes will improve. The crystalloid based resuscitation fluid in development by GanD Inc. has been designed to address all of the shortcomings of the currently available solutions.The solution, GND-001, is a cr ...

    SBIR Phase I 2018 Department of DefenseDefense Health Agency
  3. Lightweight, Compact System for Generating Lactated Ringer's Solution

    SBC: TDA Research, Inc.            Topic: DHA172011

    Currently, deployed medics are required to transport, maintain and be resupplied with liquid-based medications and materials that are heavy, expensive to transport, perishable and may require refrigeration.Many medications and materials are or will be available in concentrated or dehydrated formularies that require sterile water for injection (SWFI) to rehydrate for immediate use, such as Lactated ...

    SBIR Phase I 2018 Department of DefenseDefense Health Agency
  4. Joint Articulation And Reduction Simulator (JAARS)

    SBC: Simetri, Inc.            Topic: DHA173002

    A joint can exit its socket when it is exposed to an unhealthy level of force or rotation, causing a large amount of pain and loss of functionality in the limb. Joint dislocation can easily be diagnosed by a physical examination: palpitation of the affected joint will usually cause pain and tenderness in the patient, and the dislocated head of the bone can be felt out of its usual position in the ...

    SBIR Phase I 2018 Department of DefenseDefense Health Agency
  5. Selective Aortic Arch Perfusion Technologies for Hemorrhage-induced Cardiac Arrest

    SBC: Hays, Inc.            Topic: DHP16009

    Thereis increased interest in endovascular hemorrhagecontrol using aortic balloon occlusion to improve outcomes in preventable battlefield death from non-compressibletorso hemorrhage(NCTH). Our technology, the SABOT, is the nextgeneration in such catheters,which adds the ability of both selectivevascular bed perfusion, bypassinginjured beds, and partial perfusion. In phaseI thefeasibility and proo ...

    SBIR Phase II 2018 Department of DefenseDefense Health Agency
  6. Oxygen Production and Delivery on Demand

    SBC: Global Research and Development Inc.            Topic: DHA17B005

    This proposal is in response to the Defense Health Agency 2017 Phase I SBIR topic 17B-005.The approach is the use of a membrane oxygen pump using newly developed nano-thickness membranes with all the layers less than 1 micron total.Nanometer thickness membranes enable more oxygen output per surface area at temperatures of 300-600 C than current state-of-the -art 600-800 C membranes that are 50-300 ...

    STTR Phase I 2018 Department of DefenseDefense Health Agency
  7. Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases

    SBC: CFD Research Corporation            Topic: CBD18A001

    In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens,whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial andalphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable and ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  8. Fast Parameter Identification for Personalized Pharmacokinetics

    SBC: Autonomous Healthcare Inc            Topic: DHP17B003

    Drug dosingcan bemademore precise by using pharmacokineticand pharmacodynamicmodeling. Pharmacokinetics is thestudy of the concentration of drugs in tissueasafunction of timeand doseschedule,whereas pharmacodynamics is thestudy of therelationship between drugconcentration and drugeffect. By relating doseto resultant drugconcentration (pharmacokinetics)and concentration to effect (pharmacodynamics) ...

    STTR Phase I 2018 Department of DefenseDefense Health Agency
  9. Characterization of Piezoelectric Fibers for Sensing Shock Waves from Underwater Explosions

    SBC: ADVANCED MATERIALS AND DEVICES            Topic: DHA17C002

    This Small Business Technology Transfer (STTR) Phase I effort will demonstrate the feasibility of using piezoelectric fibers to detect shock waves from underwater explosions (UNDEX) and sensing physiological measures such as heart and respiratory rates on warfighters. Piezoelectric fibers will be characterized for their ability so sense different amplitudes and frequencies of shock and vibration. ...

    STTR Phase I 2018 Department of DefenseDefense Health Agency
  10. Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point ofCare Applications

    SBC: GENECAPTURE            Topic: CBD15C001

    GeneCapture, Inc. is proposing to develop a rapid in vitro diagnostic prototype using our patented molecular-based CAPTURE (ConfirmActive Pathogens Through Unamplified RNA Expression) assay. Based on the results and experience gained in our Phase I STTR contractHDTRA1-16C-0061: Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications, we p ...

    STTR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government